- April 22, 2022Featuring the CTSC’s Community Engagement Director, Sergio Aguilar-Gaxiola, brief clips were produced that engage multiple Sacramento, California leaders in raising awareness of the continued importance to vaccinate against COVID-19. Geared toward the Latino population, these vibrant public service announcements (PSAs) effectively promote early and continued vaccination among all ages.
- April 15, 2022
A University of Arkansas for Medical Sciences (UAMS) team’s article on COVID-19 vaccine hesitancy recently received the 2022 Clinical and Translational Science Award from the American Society for Clinical Pharmacology & Therapeutics (ASCPT). The study, “COVID-19 Vaccine Hesitancy: Race/Ethnicity, Trust and Fear,” became the most downloaded paper in 2021 from ASCPT’s journal Clinical and
- March 10, 2022UC Davis Health is partnering with Pfizer on two new clinical trials to test the COVID-19 booster vaccine in healthy adults. The UC Davis CTSC Clinical Research Center (CCRC) is providing professional patient care and research services to both clinical trials. It boasts a highly qualified staff who earned the Patient Safety Innovation Award in 2021 for supporting pioneering research on COVID-19
- January 12, 2022University of Florida faculty are leading a multistate team to boost COVID-19 and influenza vaccination rates in parts of the country where health care skepticism is common and vaccination rates are low. With the emergence of the highly contagious omicron COVID-19 variant, experts say it is more important than ever to provide people with information and access to protective vaccines. The Our
- January 11, 2022
Shots trigger exceptional antibody response by activating key helper immune cells
- November 05, 2021
The Weill Cornell Clinical and Translational Science Center (CTSC) with partner Hunter College School of Nursing, initiated a community vaccination program in February 2020 for underserved communities in New York City. Alarmed by the growing disparities in vaccination of minorities, Reverend Patrick O’Connor of First Presbyterian Church in Jamaica Queens, reached out to Julianne Imperato-McGinley
- University Of Southern California
This poster outlines and explains the purpose, strategies, and results associated with the VaccinateLA initiative, an interdisciplinary, multimedia health campaign designed to improve vaccination rates in high-disparity communities around Los Angeles, California.
- October 04, 2021
Efforts to educate and promote the COVID-19 vaccine continue and rates have gone up, but there are still communities struggling to get vaccinated. Whether low vaccination rates are due to misinformation or lack of accessibility, it has become apparent that not all communities in the U.S. are suffering in the same ways from the COVID-19 pandemic. Several groups in California have made it their
- September 30, 2021
As the country rides a new wave of the COVID-19 pandemic, it faces a riptide that’s threatening its course. The delta variant, the now-predominant strain of coronavirus, prompted President Joe Biden’s call for booster shots for all vaccinated adults on Aug. 18 and underscored discussions at a research summit that ran parallel to the president’s nationwide address. “This is, of course, something
- September 13, 2021According to the September 8, 2021, Georgia Department of Public Health COVID-19 Vaccine Dashboard, only 44% of residents are fully vaccinated. Georgia CEAL has launched an advertising campaign to address vaccine hesitancy, one of the factors contributing to the low vaccination rate especially in medically underserved and vulnerable populations. For outreach and engagement efforts in ethnic and
- September 13, 2021
Nearly 90% of people taking immunosuppressants to treat autoimmune conditions produce an antibody response to COVID-19 vaccination, but the response is weaker than those generated by healthy people, according to a study by ICTS researchers at Washington University School of Medicine.
- September 13, 2021
For Argentino Calvo, a retired firefighter and paramedic from Bluffton, South Carolina, joining a COVID-19 vaccine trial was not just a personal choice but an investment in the health of his community. Calvo participated in the Novavax vaccine trial at MUSC, which was part of a large-scale study that recruited over 30,000 patients across 119 study sites in the United States and Mexico. SCTR co
- August 23, 2021A UC Davis Health retrospective study published recently in Infection Control and Hospital Epidemiology with support from the CTSC Biostatistics team shows how quickly COVID-19 infections were reduced among health care workers when vaccines were first distributed late last year. Researchers examined the incidence of COVID-19 in thousands of UC Davis Medical Center employees before and after
- June 29, 2021
The first two COVID-19 vaccines authorized for emergency use by the Food and Drug Administration (FDA) employed a technology that had never before been used in FDA-approved vaccines. Both vaccines performed well in clinical trials, and both have been widely credited with reducing disease, but concerns remain over how long immunity induced by the new vaccine technology will last. Now, a study from